UT 1 Pharmacology – Chapter 1 Exam Questions & Key
Terms (End-of-Chapter Review)|Verified Questions with
Complete Rationales Graded A+ Latest Updated 2026
Clinical pharmacology is the study of:
A. the biological effects of chemicals.
B. drugs used to treat, prevent, or diagnose disease.
C. plant components that can be used as medicines.
D. binders and other vehicles for delivering medication.
b
Phase I drug studies involve:
A.the use of laboratory animals to test chemicals.
B. patients with the disease the drug is designed to treat.
C. mass marketing surveys of drug effects in large numbers of people.
D. healthy human volunteers who are often paid for their participation.
D
The generic name of a drug is:
A. the name assigned to the drug by the pharmaceutical company developing it.
B. the chemical name of the drug based on its chemical structure.
C. the original name assigned to the drug at the beginning of the evaluation process.
D. the name that is often used in advertising campaigns.
A
An orphan drug is a drug that:
A. has failed to go through the approval process.
B. is available in a foreign country but not in this country.
C. has been tested but is not considered to be financially viable.
D. is available without a prescription.
C
, The FDA pregnancy categories:
A. indicate a drug's potential or actual teratogenic effects.
B. are used for research purposes only.
C. list drugs that are more likely to have addicting properties.
D. are tightly regulated by the DEA
A
The storing, prescribing, and distributing of controlled substances—drugs that are more apt to
be addictive—are monitored by:
A. the FDA.
B. the Department of Commerce.
C. the Federal Bureau of Investigation.
D. the DEA.
D
Healthy young women are sometimes not able to be involved in phase I studies of drugs
because:
A. male bodies are more predictable and responsive to chemicals.
B. females are more apt to suffer problems with ova, which are formed only before birth.
C. males can tolerate the unknown adverse effects of many drugs better than females.
D. there are no standards to use to evaluate the female response.
B
A patient has been taking fluoxetine (Prozac) for several years, but when picking up the
prescription this month found that the tablets looked different and became concerned. The
nurse, checking with the pharmacist, found that fluoxetine had just become available in the
generic form and the prescription had been filled with the generic product. The nurse should
tell the patient:
A. that the new tablet may have similar effects or may not so the patient should carefully
monitor response.
B. that generic drugs are available without a prescription and they are just as safe as the brand
name medication.
C. that the law requires that prescriptions be filled with the generic form if available to cut
down the cost of medications.
Terms (End-of-Chapter Review)|Verified Questions with
Complete Rationales Graded A+ Latest Updated 2026
Clinical pharmacology is the study of:
A. the biological effects of chemicals.
B. drugs used to treat, prevent, or diagnose disease.
C. plant components that can be used as medicines.
D. binders and other vehicles for delivering medication.
b
Phase I drug studies involve:
A.the use of laboratory animals to test chemicals.
B. patients with the disease the drug is designed to treat.
C. mass marketing surveys of drug effects in large numbers of people.
D. healthy human volunteers who are often paid for their participation.
D
The generic name of a drug is:
A. the name assigned to the drug by the pharmaceutical company developing it.
B. the chemical name of the drug based on its chemical structure.
C. the original name assigned to the drug at the beginning of the evaluation process.
D. the name that is often used in advertising campaigns.
A
An orphan drug is a drug that:
A. has failed to go through the approval process.
B. is available in a foreign country but not in this country.
C. has been tested but is not considered to be financially viable.
D. is available without a prescription.
C
, The FDA pregnancy categories:
A. indicate a drug's potential or actual teratogenic effects.
B. are used for research purposes only.
C. list drugs that are more likely to have addicting properties.
D. are tightly regulated by the DEA
A
The storing, prescribing, and distributing of controlled substances—drugs that are more apt to
be addictive—are monitored by:
A. the FDA.
B. the Department of Commerce.
C. the Federal Bureau of Investigation.
D. the DEA.
D
Healthy young women are sometimes not able to be involved in phase I studies of drugs
because:
A. male bodies are more predictable and responsive to chemicals.
B. females are more apt to suffer problems with ova, which are formed only before birth.
C. males can tolerate the unknown adverse effects of many drugs better than females.
D. there are no standards to use to evaluate the female response.
B
A patient has been taking fluoxetine (Prozac) for several years, but when picking up the
prescription this month found that the tablets looked different and became concerned. The
nurse, checking with the pharmacist, found that fluoxetine had just become available in the
generic form and the prescription had been filled with the generic product. The nurse should
tell the patient:
A. that the new tablet may have similar effects or may not so the patient should carefully
monitor response.
B. that generic drugs are available without a prescription and they are just as safe as the brand
name medication.
C. that the law requires that prescriptions be filled with the generic form if available to cut
down the cost of medications.
